Clinical Trial: A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06890611) titled 'A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants' on March 18.

Brief Summary: The main purpose of this study is to evaluate the body concentration of different forms of bimagrumab, administered alone or with tirzepatide. Participation in the study will last about 4.5 months, including screening and follow-up.

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Bimagrumab

Administered SC

DRUG: Tirzepatide

Administered SC

DRUG: Bimagrumab + Tirzepatide Coformulation

Administered SC

Recruitment Status: NOT_YET_RECRUITING ...